Cargando…
High Patient Satisfaction with Daylight-Activated Methyl Aminolevulinate Cream in the Treatment of Multiple Actinic Keratoses: Results of an Observational Study in Australia
INTRODUCTION: Actinic keratoses (AK) are treated to reduce the risk of progression to squamous cell carcinoma and for symptomatic and cosmetic benefits. The objective of this observational study was to generate real-life data on the use of daylight photodynamic therapy with methyl aminolevulinate cr...
Autores principales: | See, Jo-Ann, Gebauer, Kurt, Wu, Jason K., Manoharan, Shobhan, Kerrouche, Nabil, Sullivan, John |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698198/ https://www.ncbi.nlm.nih.gov/pubmed/28905294 http://dx.doi.org/10.1007/s13555-017-0199-9 |
Ejemplares similares
-
Consensus recommendations on the use of daylight photodynamic therapy with methyl aminolevulinate cream for actinic keratoses in Australia
por: See, Jo‐Ann, et al.
Publicado: (2015) -
Patient and physician satisfaction in an observational study with methyl aminolevulinate daylight photodynamic therapy in the treatment of multiple actinic keratoses of the face and scalp in six European countries
por: Fargnoli, M.C., et al.
Publicado: (2017) -
Effective Combination of Photodynamic Therapy and Imiquimod 5% Cream in the Treatment of Actinic Keratoses: Three Cases
por: Held, Laura, et al.
Publicado: (2013) -
Visualization and Treatment of Subclinical Actinic Keratoses with Topical Imiquimod 5% Cream: An Observational Study
por: Kopera, Daisy, et al.
Publicado: (2014) -
Daylight photodynamic therapy - Experience and safety in treatment of
actinic keratoses of the face and scalp in low latitude and high brightness
region
por: Galvão, Luiz Eduardo Garcia, et al.
Publicado: (2017)